巴西开角型青光眼iStent inject治疗成本效用分析数据集
巴西开角型青光眼使用iStent inject微支架与药物治疗的成本效用分析数据,包括马尔可夫模型和增量成本效果比。

基本信息
资源简介
巴西开角型青光眼iStent inject治疗成本效用分析数据集
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 10 个文件、合计 24.18 MB,主题涵盖 Glaucoma, open-angle、Glaucoma/surgery、MIGS、iStent inject®、Trabecular micro-bypass,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《A Brazilian cost-utility analysis of trabecular micro-bypass with iStent inject® for the treatment of open-angle glaucoma》。配套论文《A Brazilian cost-utility analysis of trabecular micro-bypass with iStent inject® for the treatment of open-angle glaucoma》发表于 Revista Brasileira de Oftalmologia(2022),DOI:10.37039/1982.8551.20220049。源站首次发布:2022-07-05。
【数据内容】
源站原始描述:ABSTRACT Purpose To evaluate the cost-utility of the iStent inject® for the treatment of mild-to-moderate open-angle glaucoma (OAG) within the Brazilian Unified Health System (SUS). Methods A Markov model was developed, in which the effectiveness outcome measure was the incremental cost-effectiveness ratio (ICER: R$ / QALY quality-adjusted life-year). Direct medical costs were obtained from the SUS perspective. The base case comprised of a hypothetical cohort of patients with OAG using topical m…
【数据结构与技术规格】
文件数 10 个,合计 24.18 MB。数据集 DOI:10.6084/m9.figshare.20226666.v1。
【主题与分类】
源站学科分类:Ophthalmology。主题标签:Glaucoma, open-angle、Glaucoma/surgery、MIGS、iStent inject®、Trabecular micro-bypass、Costs and cost analysis、Cost-benefit analysis。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://scielo.figshare.com/articles/dataset/A_Brazilian_cost-utility_analysis_of_trabecular_micro-bypass_with_iStent_inject_for_the_treatment_of_open-angle_glaucoma/20226666
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Paletta Guedes, Ricardo Augusto; Souza, Camila Pepe; Dias, Leticia Lucia dos Santos; Murta, Laura; Gravina, Daniela Marcelo; Chaoubah, Alfredo (2022). A Brazilian cost-utility analysis of trabecular micro-bypass with iStent inject® for the treatment of open-angle glaucoma. SciELO journals. Dataset
【使用注意】
· 源站最后修改于 2023-06-01,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:A Brazilian cost-utility analysis of trabecular micro-bypass with iStent inject® for the treatment of open-angle glaucoma
- DOI:10.6084/m9.figshare.20226666.v1
- 发布日期:2022-07-05
- 文件数:10 个
- 文件总体积:24.18 MB
- 源站页面:https://scielo.figshare.com/articles/dataset/A_Brazilian_cost-utility_analysis_of_trabecular_micro-bypass_with_iStent_inject_for_the_treatment_of_open-angle_glaucoma/20226666
命令行下载
curl -L -o "dfc45d1dfa903b3918e3ab9082c4791d0376101d.tif" "https://ndownloader.figshare.com/files/36152307"
curl -L -o "28946c5e7b47e0244b869242beff41ef7c51ac29.png" "https://ndownloader.figshare.com/files/36152310"
curl -L -o "324ae09a2c31c48790f2fcb6b6a5fc9bf41e2ace.jpg" "https://ndownloader.figshare.com/files/36152313"
curl -L -o "e9977003d6f5e6b7020448f042af37513aafe385.tif" "https://ndownloader.figshare.com/files/36152316"
curl -L -o "7bb64c7712a34b9af33c5fff4c91ef8bfeff2d55.png" "https://ndownloader.figshare.com/files/36152319"
curl -L -o "cfb301cb380a3a88f96305a9c404e091353fb1e4.jpg" "https://ndownloader.figshare.com/files/36152322"
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/36152325"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/36152328"
文件清单
dfc45d1dfa903b3918e3ab9082c4791d0376101d.tif(11.73 MB)28946c5e7b47e0244b869242beff41ef7c51ac29.png(148.39 KB)324ae09a2c31c48790f2fcb6b6a5fc9bf41e2ace.jpg(2.91 KB)e9977003d6f5e6b7020448f042af37513aafe385.tif(11.87 MB)7bb64c7712a34b9af33c5fff4c91ef8bfeff2d55.png(403.30 KB)cfb301cb380a3a88f96305a9c404e091353fb1e4.jpg(3.83 KB)Table_1.xls(5.63 KB)Table_2.xls(5.63 KB)Table_3.xls(5.63 KB)Table_4.xls(5.63 KB)
文件总体积 24.18 MB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
ABSTRACT Purpose To evaluate the cost-utility of the iStent inject® for the treatment of mild-to-moderate open-angle glaucoma (OAG) within the Brazilian Unified Health System (SUS). Methods A Markov model was developed, in which the effectiveness outcome measure was the incremental cost-effectiveness ratio (ICER: R$ / QALY quality-adjusted life-year). Direct medical costs were obtained from the SUS perspective. The base case comprised of a hypothetical cohort of patients with OAG using topical medication and being managed according to the Clinical Protocol and Therapeutic Guidelines (PCDT) and a real-world setting based on data from Datasus. The model’s robustness through sensitivity analyses was tested. Results In the PCDT base case setting, the trabecular micro-bypass implant provided gains of 0.47 QALYs and an ICER of R$7,996.66/QALY compared to treatment with topical medication. In the real-world setting based on data from Datasus, the trabecular micro-bypass implant, provided gains of 0.47 QALYs and an ICER of R$4,485.68/QALY compared to treatment with topical medication. The results were robust to sensitivity analyses. Conclusion Incorporating iStent inject® to SUS provides an improvement in the patient’s quality of life with an additional cost that warrants the benefit provided to patients. Results may be considered cost-effective compared to topical medication.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.20226666.v1(source: https://scielo.figshare.com/articles/dataset/A_Brazilian_cost-utility_analysis_of_trabecular_micro-bypass_with_iStent_inject_for_the_treatment_of_open-angle_glaucoma/20226666)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




